Long Noncoding RNAs as a diagnostic marker for Hepatocellular Carcinoma in Patients with Cirrhosis | ||
| Zagazig University Medical Journal | ||
| Articles in Press, Accepted Manuscript, Available Online from 19 November 2025 | ||
| Document Type: Original Article | ||
| DOI: 10.21608/zumj.2025.434093.4270 | ||
| Authors | ||
| Mostafa Nasser Ali Kassem* 1; Osman Mohamed Abdu Seleem2; Sherif Abdel Aziz Sayed3; Mona Ahmed Abdelmaksoud2 | ||
| 1Department of Hepatology, Gastroenterology and Infectious Diseases, Cardiac and Gastroenterology Center, Sohag, Egypt | ||
| 2Department of Hepatology, Gastroenterology and Infectious Diseases, Faculty of Medicine, Zagazig University | ||
| 3Department of Clinical Pathology Faculty of Medicine, Sohag University | ||
| Abstract | ||
| Background: One of the most common cancers in the world and a leading cause of cancer-related death is hepatocellular carcinoma (HCC), particularly in individuals with underlying liver cirrhosis. Despite advances in diagnostic modalities, early identification of HCC remains a critical challenge. Long noncoding RNAs (lncRNAs) have emerged as promising non-invasive biomarkers for cancer detection and monitoring. So, we aimed to evaluate (LncRNAs) as diagnostic marker for HCC in Cirrhotic patient. Methods: A case-control study was conducted at The center of Hepatology and Gastroenterology (Sohag) from June 2024 to February 2025, enrolling 180 individuals divided into: Group I: 60 patients with liver cirrhosis and confirmed HCC, Group II: 60 patients with liver cirrhosis but no evidence of HCC and Group III : 60 healthy subjects. All participants underwent thorough clinical assessments, laboratory investigations, radiological imaging, and analysis of specific lncRNA expression levels in peripheral blood using quantitative real-time polymerase chain reaction (qRT-PCR). Results: When compared to both healthy controls and cirrhotic patients without cancer, the HCC group's levels of the lncRNAs under investigation were noticeably higher. Of the 120 patients in group I-II, 84 had a substantial increase in lncRNAs, and the identified lncRNAs had good sensitivity and specificity in identifying HCC. Its sensitivity and specificity are roughly 71% and 56%, respectively. Conclusion: Circulating long noncoding RNAs represent valuable non-invasive biomarkers with potential utility in the early detection of hepatocellular carcinoma among cirrhotic patients. Their incorporation into clinical practice may enhance diagnostic precision and improve patient outcomes. | ||
| Keywords | ||
| Long noncoding RNA; Hepatocellular carcinoma; Liver cirrhosis; Non-invasive biomarkers; Early cancer detection | ||
|
Statistics Article View: 2 |
||
